Genzyme ‘confident’ of FDA nod for MS drug
August 29, 2012Sales and Marketing Genzyme, Lemtrada, MS, multiple sclerosis
Genzyme insists it is on course to resubmit an existing oncology drug for the treatment of relapsing multiple sclerosis (RMS), …
Efient fails to prove superiority to Plavix
August 29, 2012Brillinta, Efient, Plavix, prasugrel, ticagrelor
Daiichi Sankyo and Lilly’s heart drug Efient has failed to come up to the mark in a late-stage trial which …
Innovation scorecard gets ABPI thumbs-up
August 29, 2012Sales and Marketing NHS, NICE, market access
An NHS ‘innovation scorecard’, showing which hospitals in England are using NICE-approved drugs – and which aren’t – has been …
AstraZeneca poaches Soirot from Roche to be new chief executive
August 28, 2012Sales and Marketing AstraZeneca, Soirot
AstraZeneca has poached Roche’s head of pharma, Pascal Soriot, to be its new chief executive. He joins on 1 October. …
Novartis’ myelofibrosis treatment approved in Europe
August 28, 2012Sales and Marketing Incyte, Jakavi, Novartis, Orphan Drugs, myelofibrosis
Novartis’ Jakavi, a new treatment for patients with myelofibrosis has been approved in Europe. The drug was co-developed with Incyte, …
GMP certification bodes well for Alexza’s lead product
August 28, 2012Manufacturing and Production Alexza, FDA, GMP, schizophrenia
US drugmaker Alexza Pharmaceuticals’ manufacturing facility for lead product Adasuve has been given a green light from the Spanish medicine …
EMA warns of sterility issues with DepoCyte
August 28, 2012Manufacturing and Production DepoCyte, Depocyt, Pacira, pharma recalls
The European Medicines Agency has issued a warning to US drugmaker Pacira Pharmaceuticals over manufacturing deficiencies at the plant making …
Pharma manufacturing news in brief
August 28, 2012Manufacturing and Production Agennix, Bilcare, United Drug, West Pharmaceutical Services B. Braun Group
Agennix trial failure affects Lonza and DSM, United Drug buys Bilcare ops, plus facility news from West Pharma and B. …
Bosch gets bigger in India; unveils new capsule filler
August 28, 2012Manufacturing and Production Bosch, India
Bosch Packaging Technology has expanded its presence in India with the opening of a new facility in Goa to help …
Ethical dilemmas add to ‘critical weaknesses’ In FDA safety monitoring
August 25, 2012Sales and Marketing Avandia, Post-marketing surveillance, pharmacovigilance
Ethical challenges are central to continuing “critical weaknesses” in the FDA’s drug safety monitoring, according to a commentary by former …
Lilly’s Alzheimer’s drug fails in phase III
August 24, 2012Sales and Marketing Alzheimer's, EXPEDITION, lilly, solanezumab
Lilly has announced that its Alzheimer’s drug candidate solanezumab has failed its primary endpoints in two key phase III trials. …
Indian reps strike over pharma’s bad ethics
August 24, 2012Sales and Marketing FMRAI, India, pharma, reps
Pharma reps in India have gone on strike to highlight what they see as the corrupt nature of the pharma …
NHS must tackle ‘tsunami of bureaucracy’
August 24, 2012Sales and Marketing CCGs, Farrar, NHS, reforms
The NHS Confederation has expressed concerns that the government’s reform of the health service will lead to a ‘tsunami of …
Pfizer and Mylan sign Japanese generics deal
August 23, 2012Sales and Marketing Mylan, Pfizer, generics
Pfizer and Mylan have struck a deal to sell generic drugs together in Japan, the world’s second biggest pharma market. …
Novartis’ Indian patent case delayed
August 23, 2012Sales and Marketing Glivec, MSF, Novartis, generics
Novartis’ court case against the Indian government has been put on hold until next month. The case was suppose to …
Boehringer’s Syrum Facebook game launch date released
August 22, 2012Medical Communications Boehringer, Facebook, Syrum
Boehringer Ingelheim has announced the launch date of its social media game Syrum. John Pugh, Boehringer’s director of digital communications …
Allergan signs $1.5 billion deal with Molecular Partners
August 22, 2012Research and Development, Sales and Marketing Allergan, Molecular Partners, eye diseases
Allergan has signed a deal potentially worth $1.5 billion with Molecular Partners to develop new drugs for certain eye diseases. …
UK government pushes through formulary changes
August 22, 2012Sales and Marketing CCGs, NHS, NICE, PCTs, UK, lottery, prescribing
The government has written to NHS prescribing leads telling them they must start to incorporate NICE guidance into their formularies. …
UK doctors not going digital for product information
August 22, 2012Medical Communications GPs, UK, digital, doctorsnet
A new survey has revealed that the majority of doctors in the UK are not looking online for information about …
Lundbeck makes two senior appointments
August 22, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andreas Eggert, Klaus Abel, Lundbeck
Lundbeck has appointed Andreas Eggert (pictured) as senior vice president for global product strategy, and Klaus Abel as vice president …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
